SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Medical Properties Trust, Inc. (MPW) , forward earnings yield 2.13%. PEG 0.83 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.83); analyst target implies upside (+67.9%).
- Forward P/E 46.9
- PEG Ratio 0.83 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Analyst consensus target $9.00 (+67.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 46/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — MPW
Valuation Multiples
P/E (TTM)0.0
Forward P/E46.9
PEG Ratio0.83
Forward PEG0.83
P/B Ratio0.00
P/S Ratio3.31
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.33
Forward EPS (Est.)$0.11
Book Value / Share$0.00
Revenue / Share$1.62
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield2.13%
Dividend Yield0.00%
Analyst Target$9.00 (+67.9%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.86 |
$541.14M |
$225.05M |
41.6% |
| 2017 |
$0.82 |
$704.75M |
$289.79M |
41.1% |
| 2018 |
$2.78 |
$784.52M |
$1.02B |
129.6% |
| 2019 |
$0.87 |
$854.2M |
$374.68M |
43.9% |
| 2020 |
$0.81 |
$1.25B |
$431.45M |
34.5% |
| 2021 |
$1.11 |
$1.54B |
$656.02M |
42.5% |
| 2022 |
$1.50 |
$1.54B |
$902.6M |
58.5% |
| 2023 |
$-0.93 |
$871.8M |
$-556.48M |
-63.8% |
| 2024 |
$-3.86 |
$995.55M |
$-2.41B |
-242.2% |
| 2025 |
$-0.33 |
$972.02M |
$-198.7M |
-20.4% |
